Dumont et al. showed that BZ treatment could improve behavioral deficits and tau pathology in P301S mice; thus, BZ is considered a promising agent for neurodegenerative diseases associated with tau pathology23. The gene discussed is MAPT; the disease is neurodegenerative disease.